POSTABSORPTIVE URINARY HYDROXYPROLINE TEST IN PATIENTS WITH METASTATIC BONE-DISEASE FROM BREAST-CANCER

被引：19
作者：
NIELL, HB [1 ]
PALMIERI, GM [1 ]
NEELY, CL [1 ]
MCDONALD, MW [1 ]
机构：
[1] UNIV TENNESSEE, CTR HLTH SCI, DEPT NUCL MED, MEMPHIS, TN 38163 USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 1981年 / 141卷 / 11期
关键词：
D O I：
10.1001/archinte.141.11.1471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Postabsorptive urine hydroxyproline (HYPRO) excretion (spot HYPRO test) was compared with the 24 h urine excretion of HYPRO in 45 patients with breast cancer and 9 normal subjects on a low-gelatin diet. A good correlation was observed between the results of these 2 tests in both groups. Patients with skeletal metastasis showed a higher spot HYPRO value than those without bone involvement and the number of lesions by bone scanning correlated with the values of spot HYPRO. In 20 of 22 patients with bone metastasis followed up for 3-19 mo., spot HYPRO values correlated well with the evolution of bone disease. The spot HYPRO test is a simple, inexpensive and accurate method for the diagnosis and follow-up of patients with skeletal metastasis from breast cancer.
引用
收藏
页码：1471 / 1473
页数：3
相关论文
共 50 条
  • [21] URINARY HYDROXYPROLINE IN MULTIPLE-MYELOMA - CORRELATION WITH CLINICAL STAGES AND BONE-DISEASE
    BOLZONELLA, S
    PACCAGNELLA, A
    SALVAGNO, L
    SILENI, VC
    DEBESI, P
    SCALELLA, P
    FIORENTINO, MV
    TUMORI JOURNAL, 1984, 70 (03): : 249 - 253
  • [22] THE CELLULAR BASIS OF METASTATIC BONE-DISEASE IN PATIENTS WITH LUNG-CANCER
    CRAMER, SF
    FRIED, L
    CARTER, KJ
    CANCER, 1981, 48 (12) : 2649 - 2660
  • [23] URINARY HYDROXYPROLINE EXCRETION IN PATIENTS WITH BREAST CANCER
    CUSCHIERI, A
    FELGATE, R
    BRITISH JOURNAL OF SURGERY, 1971, 58 (11) : 862 - +
  • [24] FLURBIPROFEN FOR THE TREATMENT OF BONE PAIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    LOMEN, PL
    SAMAL, BA
    LAMBORN, KR
    SATTLER, LP
    CRAMPTON, SL
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (3A) : 83 - 87
  • [25] BIOCHEMICAL MARKERS OF BONE TURNOVER IN PATIENTS WITH METASTATIC BONE-DISEASE
    DEMERS, LM
    COSTA, L
    CHINCHILLI, VM
    GAYDOS, L
    CURLEY, E
    LIPTON, A
    CLINICAL CHEMISTRY, 1995, 41 (10) : 1489 - 1494
  • [26] URINARY HYDROXYPROLINE EXCRETION IN EARLY AND ADVANCED BREAST-CANCER - SEQUENTIAL STUDY
    CUSCHIERI, A
    BRITISH JOURNAL OF SURGERY, 1973, 60 (10) : 800 - 803
  • [27] HYDROXYPROLINE EXCRETION IN PATIENTS WITH BREAST-CANCER AND RESPONSE TO TREATMENT
    POWLES, TJ
    LEESE, CL
    BONDY, PK
    BRITISH MEDICAL JOURNAL, 1975, 2 (5964) : 164 - 166
  • [28] EARLY MORNING HYDROXYPROLINE EXCRETION IN PATIENTS WITH BREAST-CANCER
    POWLES, TJ
    ROSSET, G
    LEESE, CL
    BONDY, PK
    CANCER, 1976, 38 (06) : 2564 - 2566
  • [29] VALUE OF URINARY HYDROXYPROLINE AND BONE ISOENZYME OF ALKALINE-PHOSPHATASE IN THE EARLY DETECTION AND FOLLOW-UP OF BONE METASTASIS IN BREAST-CANCER PATIENTS
    FRENAY, M
    NAMER, M
    BOUBLIL, JL
    KHATER, R
    VIOT, M
    FRANCOIS, E
    MILANO, G
    BULLETIN DU CANCER, 1988, 75 (06) : 533 - 539
  • [30] RECURRENT AND METASTATIC DISEASE IN BREAST-CANCER
    KOFFMANN, B
    BAEZA, MR
    REVISTA MEDICA DE CHILE, 1991, 119 (04) : 423 - 427
12345